Skip to content

Image Guided VATS vs. VATS Resection

Image Guided VATS Resection vs. VATS Resection of Lung Lesions

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03623958
Enrollment
200
Registered
2018-08-09
Start date
2018-09-11
Completion date
2027-07-31
Last updated
2025-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

image guided, lung nodule, lung cancer, lung mass

Brief summary

To evaluate workflow and outcomes of iVATS and standard VATS for small pulmonary nodules. The outcomes of the patients will be evaluated separately as there will be no direct comparison of the two arms.

Detailed description

This is a prospective phase II clinical study to evaluate iVATS and standard VATS for small pulmonary nodules. We have successfully completed and published a phase I/pilot study with 25 patients demonstrating safety and optimal procedural workflow for combining image-guidance with VATS. This phase II clinical study will further expand upon the safety and feasibility of this procedure. Additionally, this data will be used to design a phase III comparison study between iVATS and standard VATS.

Interventions

DEVICEImage guided Video-Assisted Thoracic Surgery (VATS) resection

Image guided placement of a fiducial consisting of a needle directed placement of a T-Bar next to the target lesion in order to lead the surgeon to the lung region to be removed

PROCEDUREVideo-Assisted Thoracic Surgery

Standard of Care Video-Assisted Thoracic Surgery (VATS) resection

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be 18 years and older * Subject must be deemed a candidate for the iVATS surgery, by their treating Thoracic Surgeon * Subject must have nodules/GGO or other abnormal opacity that can be accurately measured in at least one dimension with longest diameter ≤ 20 mm or 2cm * Subject's lesions that are located in the outer half portion of the lung/lobe. * Subjects must be evaluated at BWH and/or DFCI Thoracic Surgery outpatient clinics

Exclusion criteria

* If participant is a pregnant woman or breast feeding they will not be eligible. * If treating thoracic surgeon deems the participant not eligible for the study.

Design outcomes

Primary

MeasureTime frameDescription
Operating Room Time3 years to completeThe time (in min.) from incision to close

Secondary

MeasureTime frameDescription
Time to T-bar placement3 yearsThe time from patient ready for surgery to placement of t-bar
Time for induction to incision3 yearsTime (in min) from induction to incision made
Hospital Length of Stay3 yearsLength of hospital stay (in days) in both arms
Radiation Exposure3 yearsThe radiation exposure (mSV) in the iVATS arm

Other

MeasureTime frameDescription
Quantitative Analysis of CT scans3 yearsTo collect imaging data from pre-operative and post-operative CT scans for quantitative analysis from both arm.

Countries

United States

Contacts

Primary ContactJulianne S Barlow
jbarlow1@bwh.harvard.edu617-525-8704

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026